Johnna R Swartz1, Douglas E Williamson, Ahmad R Hariri. 1. From the Center for Developmental Science, University of North Carolina at Chapel Hill; the Department of Psychology and Neuroscience and the Institute for Genome Sciences and Policy, Duke University, Durham, N.C.; and the Translational Epidemiology Program, Department of Psychiatry, University of Texas Health Sciences Center at San Antonio.
Abstract
OBJECTIVE: Although heightened amygdala reactivity is observed in patients with major depression, two critical gaps in our knowledge remain. First, it is unclear whether heightened amygdala reactivity is a premorbid vulnerability or a consequence of the disorder. Second, it is unknown how and when this neural phenotype develops. The authors sought to address these gaps by evaluating developmental change in threat-related amygdala reactivity in adolescents at high or low risk for depression based on family history, before onset of disorder. METHOD: At baseline and again 2 years later, adolescents (initially 11-15 years of age) participated in a functional MRI paradigm that elicited threat-related amygdala reactivity. After quality control, data were available for 232 adolescents at wave 1 and 197 adolescents at wave 2; longitudinal data meeting quality control at both waves were available for 157 of these participants. Change in amygdala reactivity was assessed as a function of family history of depression and severity of stressful life events. RESULTS: Threat-related amygdala reactivity increased with age in participants with a positive family history regardless of the severity of life stress reported, and it increased in adolescents with a negative family history who reported relatively severe life stress. These changes in amygdala reactivity with age occurred in the absence of clinical disorder or increases in depressive symptoms. CONCLUSIONS: These results suggest that heightened amygdala reactivity emerges during adolescence, prior to the development of depression, as a function of familial risk or, in the absence of familial risk, stressful life events.
OBJECTIVE: Although heightened amygdala reactivity is observed in patients with major depression, two critical gaps in our knowledge remain. First, it is unclear whether heightened amygdala reactivity is a premorbid vulnerability or a consequence of the disorder. Second, it is unknown how and when this neural phenotype develops. The authors sought to address these gaps by evaluating developmental change in threat-related amygdala reactivity in adolescents at high or low risk for depression based on family history, before onset of disorder. METHOD: At baseline and again 2 years later, adolescents (initially 11-15 years of age) participated in a functional MRI paradigm that elicited threat-related amygdala reactivity. After quality control, data were available for 232 adolescents at wave 1 and 197 adolescents at wave 2; longitudinal data meeting quality control at both waves were available for 157 of these participants. Change in amygdala reactivity was assessed as a function of family history of depression and severity of stressful life events. RESULTS: Threat-related amygdala reactivity increased with age in participants with a positive family history regardless of the severity of life stress reported, and it increased in adolescents with a negative family history who reported relatively severe life stress. These changes in amygdala reactivity with age occurred in the absence of clinical disorder or increases in depressive symptoms. CONCLUSIONS: These results suggest that heightened amygdala reactivity emerges during adolescence, prior to the development of depression, as a function of familial risk or, in the absence of familial risk, stressful life events.
Authors: Johnna R Swartz; Melisa Carrasco; Jillian Lee Wiggins; Moriah E Thomason; Christopher S Monk Journal: Neuroimage Date: 2013-08-17 Impact factor: 6.556
Authors: Nynke A Groenewold; Esther M Opmeer; Peter de Jonge; André Aleman; Sergi G Costafreda Journal: Neurosci Biobehav Rev Date: 2012-12-01 Impact factor: 8.989
Authors: Dylan G Gee; Kathryn L Humphreys; Jessica Flannery; Bonnie Goff; Eva H Telzer; Mor Shapiro; Todd A Hare; Susan Y Bookheimer; Nim Tottenham Journal: J Neurosci Date: 2013-03-06 Impact factor: 6.167
Authors: J Paul Hamilton; Amit Etkin; Daniella J Furman; Maria G Lemus; Rebecca F Johnson; Ian H Gotlib Journal: Am J Psychiatry Date: 2012-07 Impact factor: 18.112
Authors: Anna J Watters; Ian H Gotlib; Anthony W F Harris; Philip M Boyce; Leanne M Williams Journal: J Affect Disord Date: 2013-06-10 Impact factor: 4.839
Authors: Alexander J Shackman; Do P M Tromp; Melissa D Stockbridge; Claire M Kaplan; Rachael M Tillman; Andrew S Fox Journal: Psychol Bull Date: 2016-10-10 Impact factor: 17.737
Authors: Katie L Burkhouse; Autumn Kujawa; Kate Keenan; Heide Klumpp; Kate D Fitzgerald; Christopher S Monk; K Luan Phan Journal: Psychiatry Res Neuroimaging Date: 2017-03-09 Impact factor: 2.376
Authors: Nourhan M Elsayed; M Justin Kim; Kristina M Fields; Rene L Olvera; Ahmad R Hariri; Douglas E Williamson Journal: J Am Acad Child Adolesc Psychiatry Date: 2018-06-18 Impact factor: 8.829